Big Pharma Fined $3.75 Billion in Fraud Penalties in Fiscal 2013

According to the U.S. Departments of Justice and Health and Human Services, these departments recovered $4.3 billion in criminal and civil fines in the 2013 fiscal year, which ended in September 2013.  This is a $100 million increase from the 2012 fiscal year.  The five-year total in fines has now reached $19.2 billion.  Pharma drugmakers [...]

March 3rd, 2014|Drug and Medical Device Litigation|Comments Off on Big Pharma Fined $3.75 Billion in Fraud Penalties in Fiscal 2013
Read More

Drugs, Advertising, and Risks Associated with Direct to Consumer Ads

If you have watched a news program, sporting event, or network television show recently you have seen multiple ads for drugs or devices that will change your life.  Whether it is “Larry the cable guy” for the “purple” pill, a handsome athletic looking couple looking for the right moment assisted by a “blue” pill, an [...]

October 23rd, 2013|Drug and Medical Device Litigation|Comments Off on Drugs, Advertising, and Risks Associated with Direct to Consumer Ads
Read More